Compound Monograph
Thymol
Thymol is thyme's chemotype-defining monoterpene phenol and the antiseptic principle behind thyme and oregano oils: a membrane-disrupting antibacterial and antifungal, orally bioavailable but rapidly conjugated to sulfate/glucuronide, and a listed dental antiseptic (a Listerine and chlorhexidine-varnish ingredient). Its strong data are the isolate in the lab; the human evidence is mostly the oil.
Sources · 9
Where Does It Come From?
Thymol is a naturally occurring monoterpenoid (monoterpene phenol), found in Thyme, Oregano, Savory and 6 other sources. It is well tolerated orally (low toxicity).
Source Arnica Arnica montana Herb monograph →
Source Black Walnut Juglans nigra Herb monograph →
Source Catnip Nepeta cataria Herb monograph →
Source Damiana Turnera diffusa Herb monograph →
Source Oregano Origanum vulgare Herb monograph → Concentration
Content by Source
Reported concentrations across the plants that contain thymol — the bar marks the typical level, the line shows the reported range.
Literature figures for varying plant parts and preparations. Read them as a comparative guide, not exact assays.
Thymol at a Glance
Thymol is a monoterpene phenol (2-isopropyl-5-methylphenol) and the aromatic principle that gives thyme its warm, medicinal bite. It is the chemotype-defining constituent of common thyme — in the thymol chemotype it makes up roughly 20–55% of the essential oil — and it recurs across oregano, savory, ajwain and, as a minor volatile, damiana 1,
Its defining action is antisepsis. As a small, lipophilic phenol it inserts into and permeabilises microbial membranes, making it broadly antibacterial and antifungal, and this is what underwrites its most tangible human use: thymol is a listed dental antiseptic — one of the four essential oils in Listerine and the co-active in chlorhexidine–thymol cavity varnishes 3,
The honest posture is the usual compound-page one. The strong, mechanistically clean data are for the isolated molecule in the lab; the human evidence is largely for thyme/oregano oil or multi-ingredient mouthwash, not weighed thymol. And “phenol” cuts both ways — the same reactivity that disrupts microbes makes concentrated thymol a mucosal and skin irritant, even though at dietary and mouthwash levels it is regarded as safe 1Reference 1Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical DevelopmentView study →.
Thymol vs. Carvacrol
Thymol’s closest relative is carvacrol, and the two are constantly discussed together — they are positional isomers, the same atoms with the hydroxyl group moved to a different ring carbon. Both are monoterpene phenols, both are membrane-disrupting antimicrobials built on a free phenolic hydroxyl, and they frequently co-occur (and act synergistically) in the same oils 4,
The practical difference is which plant leads with which. Thymol dominates the thymol chemotype of common thyme; carvacrol dominates oregano and savory. Thyme’s carvacrol chemotype flips the ratio, and the two phenols vary inversely with their shared precursors p-cymene and γ-terpinene 2Reference 2Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacyView study →. Functionally they are near-interchangeable antiseptics; where they differ is in sensory profile and in the fine detail of some assays — a reason the literature reports them as a phenol pair rather than treating either in isolation 4,
Dental & Antiseptic Uses
This is thymol’s one genuinely established human-use footprint — and it is a topical/oral-cavity antiseptic role, not a systemic drug.
Thymol is one of the four essential oils in Listerine (with menthol, eucalyptol and methyl salicylate). In a component-by-component comparison it had the lowest MIC and bactericidal/fungicidal concentrations of the phenols tested, and was individually the most potent against Eikenella corrodens and Candida albicans — though the study also found the fixed Listerine concentrations produced no clear synergy between the phenols, i.e. the formula works as a sum of active ingredients rather than a potentiated blend 11Reference 11A Preliminary Investigation on the Antimicrobial Activity of Listerine, Its Components, and of Mixtures ThereofView study →. Thymol is likewise the co-active, at 1%, in chlorhexidine–thymol cavity varnishes (e.g. Cervitec) used to suppress mutans streptococci on tooth surfaces.
The efficacy caveat is real. These varnishes reliably reduce cariogenic bacteria, but their effect on actual caries is mixed: a randomised trial of chlorhexidine–thymol varnish in 13–16-year-olds found no benefit on approximal caries in a low-caries population 12Reference 12Effect of a varnish containing chlorhexidine and thymol (Cervitec) on approximal caries in 13- to 16-year-old schoolchildren in a low caries areaView study →. So the antiseptic activity is well established; the clinical outcome is formulation- and population-dependent, and it belongs to the mouthwash/varnish product, not to isolated thymol.
What It's Used For
Thymol’s pharmacology is broad and mechanistically coherent, but it splits sharply by evidence type: an abundant in-vitro and rodent isolate literature, versus human data that are almost entirely the oil or a mouthwash 1,
Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Thymol’s isolate evidence is preclinical, so scores stay modest by design. Each row links to its write-up.
Thymol’s strongest and best-isolated evidence. Being a small lipophilic phenol, it partitions into the cytoplasmic membrane, increasing permeability and dissipating membrane potential so that ions and intracellular contents leak out — the mechanism worked out for thymol (and its isomer carvacrol) against Escherichia coli, where treated cells lose membrane integrity and potential 3Reference 3The antibacterial mechanism of carvacrol and thymol against Escherichia coliView study →.
It is broadly active across Gram-positive and Gram-negative bacteria reviewed for the genus Thymus 2Reference 2Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacyView study →, and this membrane action is the basis of its oral-antiseptic role, where it had the lowest MIC of the Listerine phenols 11Reference 11A Preliminary Investigation on the Antimicrobial Activity of Listerine, Its Components, and of Mixtures ThereofView study →.
Gap: almost entirely in-vitro or oral-cavity/surface use — the dish-level MICs are not systemic blood levels, and there is no isolated-thymol infection trial (see Pharmacokinetics) 8,
A clean isolate signal. Against Candida species thymol is fungicidal (not merely fungistatic like fluconazole), acting by disrupting ergosterol biosynthesis and membrane integrity — the fungal-membrane analogue of its antibacterial mechanism — with low toxicity to human cells in the same assays 4Reference 4Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against CandidaView study →. In combination it is synergistic: carvacrol + thymol together impair single- and mixed-species biofilms of C. albicans and Staphylococcus epidermidis that resist single agents 5Reference 5Synergistic antimicrobial combination of carvacrol and thymol impairs single and mixed-species biofilms of Candida albicans and Staphylococcus epidermidisView study →.
Gap: in-vitro MIC/biofilm work and one mechanism story; no human antifungal trial of the isolate, and the effective concentrations are topical/mucosal, not systemic 4,
A consistent preclinical anti-inflammatory signal running through NF-κB. In LPS-stimulated macrophages, thymol (with carvacrol) modulates inflammatory transcription factors and lowers pro-inflammatory cytokine expression 6Reference 6Modulatory effects of thymol and carvacrol on inflammatory transcription factors in lipopolysaccharide-treated macrophagesView study →; in a mouse model of LPS-induced acute lung injury, thymol given before or after challenge reduced TNF-α, IL-6 and neutrophil influx, suppressing NF-κB and up-regulating the Nrf2/HO-1 antioxidant axis 7Reference 7AnimalProtective effects of thymol on LPS-induced acute lung injury in miceView study →.
Gap: macrophage and rodent models only, at research doses; the “NF-κB/leukotriene” framing is supported for NF-κB/Nrf2 but not for a specific thymol leukotriene target, and there is no human anti-inflammatory trial of the isolate 6,
As a phenol, thymol is a direct radical scavenger and also induces endogenous antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase), with strong DPPH / hydroxyl-radical scavenging in the assays compiled in its pharmacology review 1Reference 1Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical DevelopmentView study →; the same Nrf2/HO-1 induction seen in the lung-injury model reinforces an indirect antioxidant route 7Reference 7AnimalProtective effects of thymol on LPS-induced acute lung injury in miceView study →.
Gap: largely descriptive in-vitro and animal data; thymol is one contributor among the phenolics of any whole extract, and no human antioxidant outcome rests on the isolate 1Reference 1Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical DevelopmentView study →.
A plausible basis for thyme’s traditional use for cramping cough and gut spasm. In isolated rat ileum, thymol produced dose-dependent relaxation of acetylcholine-induced contractions, becoming complete (and irreversible) at high concentration — the authors favouring competitive antagonism at muscarinic receptors, while other work implicates calcium-influx block 10Reference 10AnimalThe effect of thymol on acetylcholine-induced contractions of the rat ileum and uterus under ex vivo conditionsView study →.
Gap: ex-vivo tissue and animal data, with the exact mechanism (muscarinic vs. L-type Ca²⁺ channel) still unsettled; no human antispasmodic trial of isolated thymol 10Reference 10AnimalThe effect of thymol on acetylcholine-induced contractions of the rat ileum and uterus under ex vivo conditionsView study →.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| Cytoplasmic-membrane permeabilisation / depolarisation | ion and content leak, loss of membrane potential → bactericidal | antibacterial / antiseptic (primary) |
| Free phenolic hydroxyl (structure–activity) | the –OH drives the antimicrobial potency shared with carvacrol | antimicrobial SAR |
| Fungal ergosterol biosynthesis + membrane integrity | fungicidal; osmotic imbalance, content extrusion in Candida | antifungal |
| NF-κB suppression | ↓ TNF-α, IL-6, IL-1β transcription | anti-inflammatory |
| Nrf2 / HO-1 induction | ↑ antioxidant defences (indirect antioxidant) | anti-inflammatoryantioxidant |
| Phenolic radical scavenging + SOD/CAT/GPx induction | direct + enzymatic antioxidant capacity | antioxidant |
| Smooth-muscle muscarinic / Ca²⁺ handling | relaxation of ACh-induced contraction | GI / antispasmodic |
The load-bearing point is the membrane: one lipophilic-phenol action — inserting into and permeabilising lipid bilayers — explains the antibacterial, antifungal and antiseptic activity together, while the NF-κB/Nrf2 and antioxidant effects are separate, preclinical layers.
Pharmacokinetics
Thymol has the best-characterised human PK of any thyme volatile, and the result is striking: after oral dosing in people, no free thymol is detectable in plasma or urine — it is absorbed but rapidly and completely conjugated to thymol sulfate and thymol glucuronide 8Reference 8Systemic availability and pharmacokinetics of thymol in humansView study →. Peak plasma thymol-sulfate averaged ~93 ng/ml at about 2 hours, the terminal half-life was ~10 hours, and ~16% of the dose was recovered as the two conjugates in 24-hour urine 8Reference 8Systemic availability and pharmacokinetics of thymol in humansView study →. Phase-I metabolism in human liver microsomes is handled predominantly by CYP2A6 9Reference 9Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomesView study →. The practical implication mirrors carvacrol’s: the impressive in-vitro MICs are surface/mucosal phenomena (mouth, gut lumen, skin), not systemic blood concentrations — which is exactly why thymol’s real human use is a local antiseptic, not an oral antimicrobial drug.
Clinical Trials
There is no completed RCT of isolated thymol for any indication. The human evidence is for thyme/oregano essential oil, multi-oil mouthwash (Listerine) or chlorhexidine–thymol varnish — for example, a randomised trial of chlorhexidine–thymol varnish that found no approximal-caries benefit in a low-caries cohort despite reducing cariogenic bacteria 12Reference 12Effect of a varnish containing chlorhexidine and thymol (Cervitec) on approximal caries in 13- to 16-year-old schoolchildren in a low caries areaView study →. Everything human-relevant traces to the product, not the weighed molecule.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| —(isolate); oral-antiseptic products only 11, | — | — | Extensive(antimicrobial, anti-inflammatory, antioxidant) |
Last checked: July 2026.
Isolate vs. Plant Studies
Thymol sits between the two poles. Its mechanistic and antimicrobial data are overwhelmingly the isolated molecule — the membrane-permeabilisation work 3Reference 3The antibacterial mechanism of carvacrol and thymol against Escherichia coliView study →, the Candida ergosterol/membrane studies 4Reference 4Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against CandidaView study →, the biofilm synergy 5Reference 5Synergistic antimicrobial combination of carvacrol and thymol impairs single and mixed-species biofilms of Candida albicans and Staphylococcus epidermidisView study →, the macrophage and lung-injury models 6,
The human efficacy evidence, by contrast, is the product: the antiseptic data are for Listerine and its component mixtures 11Reference 11A Preliminary Investigation on the Antimicrobial Activity of Listerine, Its Components, and of Mixtures ThereofView study → and for chlorhexidine–thymol varnish 12Reference 12Effect of a varnish containing chlorhexidine and thymol (Cervitec) on approximal caries in 13- to 16-year-old schoolchildren in a low caries areaView study →, not for thymol dosed alone. And in the whole plant, thymol is inseparable from its co-phenol carvacrol and the precursor terpenes 2Reference 2Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacyView study →. The correct framing: strong isolate mechanism + solid human PK + no isolate efficacy trial, with the clinical footprint belonging to thyme/oregano oil and multi-ingredient oral products.
Its Role in Plants
In thyme and its relatives, thymol is a defence phenol — an antimicrobial, antifeedant component of the essential oil stored in glandular trichomes, part of why these Lamiaceae resist microbial and insect attack.
Its biosynthesis is a classic and recently-revised story. It begins with the universal monoterpene precursor geranyl diphosphate, cyclised to γ-terpinene; the long-standing model (from Thymus vulgaris enzyme work) had γ-terpinene aromatised to p-cymene and then hydroxylated to thymol 13Reference 13Biosynthesis of aromatic monoterpenes: conversion of gamma-terpinene to p-cymene and thymol in Thymus vulgaris LView study →. Modern genetics revised the middle step: CYP71D-subfamily cytochrome P450s oxidise γ-terpinene to an unstable cyclohexadienol/dienone intermediate that a short-chain dehydrogenase converts to thymol or carvacrol — not through p-cymene, which is now thought to arise as a side-reaction from the same unstable intermediate 14Reference 14The biosynthesis of thymol, carvacrol, and thymohydroquinone in Lamiaceae proceeds via cytochrome P450s and a short-chain dehydrogenaseView study →. Whether a plant makes thymol or its isomer carvacrol comes down to which CYP71D variant and dehydrogenase it expresses — the molecular basis of the thyme chemotypes.
Prevalence in Nature
Thymol is a Lamiaceae (mint-family) signature phenol, concentrated in the essential oils of aromatic herbs rather than spread thinly through the plant. Its richest and most consistent source is the thymol chemotype of common thyme (Thymus vulgaris), where it can be ~20–55% of the essential oil 2Reference 2Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacyView study →; the figure swings enormously with chemotype (thymol- vs carvacrol- vs linalool- vs geraniol-dominant), plant part (aerial parts at flowering are richest), season and provenance, so a species name alone does not predict thymol content.
Beyond thyme it is a major phenol of some oregano (Origanum) and savory (Satureja) oils — usually second to carvacrol — and is famously abundant in ajwain (Trachyspermum ammi) seed oil, an Apiaceae outlier and one of the richest dietary thymol sources. Horsemint (Monarda) species are an industrial thymol source. In damiana (Turnera diffusa) thymol is only a minor essential-oil volatile, one of many monoterpenes rather than a defining constituent. Thymol almost always travels with its isomer carvacrol and their shared precursors p-cymene and γ-terpinene 2Reference 2Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacyView study →.
Discovery & Synthesis
Thymol is one of the oldest isolated plant constituents. The German chemist Caspar Neumann obtained it in 1719 as a crystalline “camphor of thyme” (Camphora thymi) from distilled thyme oil — more than a century before its structure was understood. The French chemist Alexandre Lallemand named it “thymol” and established its empirical formula in 1853, and Oskar Widman achieved the first synthesis in 1882.
Manufacture today is largely synthetic: thymol is produced industrially by the acid-catalysed alkylation of m-cresol with propene (Friedel–Crafts isopropylation), giving a consistent, inexpensive product for the flavour, fragrance, antiseptic and agrochemical markets. Natural thymol is still crystallised from thymol-rich oils (thyme, ajwain, Monarda) where a botanical-source label or the whole-oil matrix is wanted.
Patents: not yet researched.
Toxicity & Safety
Thymol carries a low flag. It is FDA GRAS as a food flavouring and is reviewed as having negligible toxicity at the levels used in food, mouthwash and topical antiseptics 1Reference 1Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical DevelopmentView study →. The caveats are those of any concentrated phenol, and of the essential oils that carry it — not of dietary or mouthwash exposure.
The dominant practical concern is irritation in concentrated form. Pure thymol and undiluted thyme/oregano oil can irritate skin and mucous membranes — the same membrane-disrupting reactivity that makes thymol antimicrobial — so concentrated oils should be diluted and kept away from children. In cell culture, thymol is cytotoxic at high concentrations even though it is well tolerated at antiseptic and food levels 1Reference 1Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical DevelopmentView study →. Because human dosing is so low and free thymol does not circulate (it is rapidly conjugated) 8Reference 8Systemic availability and pharmacokinetics of thymol in humansView study →, systemic thymol toxicity from ordinary use is not a realistic exposure; the relevant risks are local irritation and accidental ingestion of concentrated essential oil.
Drug-interaction data are theoretical: as a CYP2A6 and UGT substrate, thymol could in principle interact with co-metabolised agents 9Reference 9Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomesView study →, but no human interaction studies exist. Reproductive/developmental decisions belong to the herb or product page where intake is decided, not to this molecule page.
- Low-toxicity, GRAS phenol. A food flavouring and established oral antiseptic, well tolerated at dietary, mouthwash and topical-antiseptic levels 1Reference 1Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical DevelopmentView study →.
- No systemic accumulation. Orally absorbed but rapidly conjugated to sulfate/glucuronide, with no free thymol circulating 8Reference 8Systemic availability and pharmacokinetics of thymol in humansView study →.
- Concentrated form is a mucosal / skin irritant. Pure thymol and undiluted thyme/oregano oil can irritate; dilute essential oils and keep away from children 1Reference 1Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical DevelopmentView study →.
- Accidental ingestion of concentrated oil. The meaningful exposure is the concentrate, not the herb or the mouthwash.
- Theoretical CYP2A6 / UGT interactions. A metabolic-substrate possibility only; no human interaction data 9Reference 9Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomesView study →.
Dosage
There is no established or recommended systemic human dose for isolated thymol — the figures here are use-levels and research references, not a recommendation.
| Context | Typical level |
|---|---|
| Mouthwash (Listerine, thymol component) | ~0.06% |
| Chlorhexidine–thymol dental varnish | 1% |
| Food / flavour use | trace (GRAS) |
| Preclinical rodent efficacy studies | tens of mg/kg (animal) |
Its real human “dose” is topical / oral-cavity antisepsis at low concentration in a multi-ingredient product 11,
References
- Nagoor Meeran MF, Javed H, Al Taee H, Azimullah S, Ojha SK (2017). Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/28694777/
- Nabavi SM, Marchese A, Izadi M, Curti V, Daglia M, Nabavi SF (2015). Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacy. Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/25466031/
- Xu J, Zhou F, Ji BP, Pei RS, Xu N (2008). The antibacterial mechanism of carvacrol and thymol against Escherichia coli. Letters in Applied Microbiology. https://pubmed.ncbi.nlm.nih.gov/19552781/
- Ahmad A, Khan A, Akhtar F, Yousuf S, Xess I, Khan LA, Manzoor N (2011). Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. European Journal of Clinical Microbiology & Infectious Diseases. https://pubmed.ncbi.nlm.nih.gov/20835742/
- Swetha TK, Vikraman A, Nithya C, Hari Prasath N, Pandian SK (2020). Synergistic antimicrobial combination of carvacrol and thymol impairs single and mixed-species biofilms of Candida albicans and Staphylococcus epidermidis. Biofouling. https://pubmed.ncbi.nlm.nih.gov/33435734/
- Gholijani N, Gharagozloo M, Farjadian S, Amirghofran Z (2016). Modulatory effects of thymol and carvacrol on inflammatory transcription factors in lipopolysaccharide-treated macrophages. Journal of Immunotoxicology. https://pubmed.ncbi.nlm.nih.gov/25812626/
- Yao L, Hou G, Wang L, Zuo XS (2018). Protective effects of thymol on LPS-induced acute lung injury in mice. Microbial Pathogenesis. https://pubmed.ncbi.nlm.nih.gov/29284133/
- Kohlert C, Schindler G, März RW, Abel G, Brinkhaus B, Derendorf H, Gräfe EU, Veit M (2002). Systemic availability and pharmacokinetics of thymol in humans. Journal of Clinical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/12092740/
- Dong RH, Fang ZZ, Zhu LL, Ge GB, Cao YF, Li XB, Hu CM, Yang L, Liu ZY (2012). Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomes. Die Pharmazie. https://pubmed.ncbi.nlm.nih.gov/23346763/
- Premrov Bajuk B, Prem L, Vake T, Žnidaršič N, Snoj T (2022). The effect of thymol on acetylcholine-induced contractions of the rat ileum and uterus under ex vivo conditions. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.990654
- Vlachojannis C, Chrubasik-Hausmann S, Hellwig E, Al-Ahmad A (2015). A Preliminary Investigation on the Antimicrobial Activity of Listerine, Its Components, and of Mixtures Thereof. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/26104602/
- Haukali G, Poulsen S (2003). Effect of a varnish containing chlorhexidine and thymol (Cervitec) on approximal caries in 13- to 16-year-old schoolchildren in a low caries area. Caries Research. https://pubmed.ncbi.nlm.nih.gov/12740541/
- Poulose AJ, Croteau R (1978). Biosynthesis of aromatic monoterpenes: conversion of gamma-terpinene to p-cymene and thymol in Thymus vulgaris L. Archives of Biochemistry and Biophysics. https://pubmed.ncbi.nlm.nih.gov/666313/
- Krause ST, Liao P, Crocoll C, Boachon B, Förster C, Leidecker F, Wiese N, Zhao D, Wood JC, Buell CR, Gershenzon J, Dudareva N, Degenhardt J (2021). The biosynthesis of thymol, carvacrol, and thymohydroquinone in Lamiaceae proceeds via cytochrome P450s and a short-chain dehydrogenase. Proceedings of the National Academy of Sciences. https://pubmed.ncbi.nlm.nih.gov/34930840/
